Cardiac Resynchronization Therapy in Heart Failure: Rationale, Results, Indications, Limits and Perspectives
Journal Title: Journal of Cardiovascular Medicine and Cardiology - Year 2014, Vol 1, Issue 1
Abstract
Heart Failure is the result of heterogeneous structural heart diseases, especially ischemic disease, and is becoming increasingly common in all Western countries. Many patients continue to be symptomatic in spite of progress in pharmacological therapy, and the risk of mortality remains high in the most advanced functional classes. Cardiac resynchronization therapy can be used as a therapeutic strategy for alleviating symptoms and reducing mortality in selected patients with heart failure. Cardiac resynchronization therapy provides both immediate and medium/long-term results. The immediate results are the reduced QRS duration, the synchrony restoration between the ventricles and between the lateral and septal walls of the left ventricle, the reduced mitral regurgitation and the increased stroke volume. In the medium/long term, left ventricular reverse remodeling occurs and left ventricular ejection fraction is increased. Several trials have documented both increased functional capacity and improvements in quality of life and New York Heart Association class. Moreover, cardiac resynchronization therapy has been seen to reduce HF hospitalizations and mortality and the total number of days of hospitalization. In order to reduce the percentage of non-responders to cardiac resynchronization therapy, it is necessary to optimize the prognostic stratification of candidates for implantation through multi-parameter evaluations and to ensure correct device programming with periodic updates which are widely recommended but not so often performed. Whether indications should be extended will need to be evaluated in view of the known complications mainly associated with lead implantation.
Authors and Affiliations
Andrea Andrea, Sergio Valsecchi, Umberto Riva, Maria Grazia Bendini, Massimo Leggio
Keywords
Related Articles
- EP ID EP231469
- DOI 10.17352/2455-2976.000004
- Views 122
- Downloads 0
Reperfusion of Acute Myocardial Infarction in the elderly (clinical characteristics and prognosis) Results of the IMSS Nuevo León infarction code program
Background: The age is an important prognostic factor in patients with acute myocardial infarction. To find no similar data in the Mexican population, it seeks to establish the characteristics and prognosis of older adul...
Sinus Valsalva Dissection with Involvement Right Ostium Artery during PCI Rescue: A Rare Complication
Aorto-coronary dissection is a rare complication that occur during percutaneous coronary intervention, but life threatening. We describe a case of limited iatrogenic dissection of Valsalvae, with ostium right coronary ar...
Extraction of an Infected Active Fixation Coronary Sinus Lead with the Aid of a Tissue Stabilizer
We present a 49-year-old man who required extraction of a cardiac resynchronization device due to lead infection. While 2 leads were successfully retrieved by a transvenous approach the third one with active fixation and...
“C” Trouble: Class IC Anti-arrhythmic Toxicity
The most common cardiac arrhythmia encountered in clinical practice is atrial fibrillation (AFib). AFib has significant effects on long-term mortality and stroke, and contributes greatly to overall healthcare costs, affe...
Nature of Human Gut Microbiome: How do they play in Cardiovascular Disease?
Cardiovascular disease is the number one killer of death around the world. Most of the cardiovascular diseases are caused by sedentary life style, bad eating habit, tobacco smoking, high alcohol intake, dyslipidemia and...